From the NAMI National web site.

Return to information page on BPD.

Return to Home.

 

Borderline Personality Disorder (BPD)

What is BPD?

Borderline Personality Disorder (BPD) is characterized by impulsivity and instability in mood, self-image, and personal relationships. It is fairly common and is diagnosed more often in females than males.

What are the symptoms of BPD?
Individuals with BPD have several of the following symptoms:

  • marked mood swings with periods of intense depression, irritability, and/or anxiety lasting a few hours to a few days;
  • inappropriate, intense, or uncontrolled anger;
  • impulsiveness in spending, sex, substance use, shoplifting, reckless driving, or binge eating;
  • recurring suicidal threats or self-injurious behavior;
  • unstable, intense personal relationships with extreme, black and white views of people and experiences, sometimes alternating between "all good" idealization and "all bad" devaluation;
  • marked, persistent uncertainty about self-image, long term goals, friendships, and values;
  • chronic boredom or feelings of emptiness; and
  • frantic efforts to avoid abandonment, either real or imagined.

What causes BPD?
The causes of BPD are unclear, although psychological and biological factors may be involved. Originally thought to "border on" schizophrenia, BPD now appears to be more related to serious depressive illness. In some cases, neurological or attention-deficit disorders play a role. Biological problems may cause mood instability and lack of impulse control, which in turn may contribute to troubled relationships. Difficulties in psychological development during childhood, perhaps associated with neglect, abuse, or inconsistent parenting, may create identity and personality problems. More research is needed to clarify the psychological and/or biological factors causing BPD.

How is BPD treated?
A combination of psychotherapy and medication appears to provide the best results for treatment of BPD. Medications can be useful in reducing anxiety, depression, and disruptive impulses. Relief of such symptoms may help the individual deal with harmful patterns of thinking and interacting that disrupt daily activities.

However, medications do not correct ingrained character difficulties. Long-term outpatient psychotherapy and group therapy (if the individual is carefully matched to the group) can be helpful. Short-term hospitalization may be necessary during times of extreme stress, impulsive behavior, or substance abuse.

While some individuals respond dramatically, more often treatment is difficult and long term. Symptoms of the disorder are not easily changed and often interfere with therapy. Periods of improvement may alternate with periods of worsening. Fortunately, over time most individuals achieve a significant reduction in symptoms and improved functioning.

Can other disorders co-occur with BPD?
Yes. Determining whether other psychiatric disorders may be involved is critical. BPD may be accompanied by serious depressive illness (including bipolar disorder), eating disorders, and alcohol or drug abuse. About 50 percent of people with BPD experience episodes of serious depression. At these times, the "usual" depression becomes more intense and steady, and sleep and appetite disturbances may occur or worsen. These symptoms, and the other disorders mentioned above, may require specific treatment. A neurological evaluation may be necessary for some individuals.

What medications are prescribed for BPD?
Antidepressants, anticonvulsants, and short-term use of neuroleptics are common for BPD. Decisions about medication use should be made cooperatively between the individual and the therapist. Issues to be considered include the person's willingness to take the medication as prescribed, and the possible benefits, risks, and side effects of the medication, particularly the risk of overdose.

References
Diagnostic and Statistical Manual of Mental Disorders, Third Edition Revised (DSM III-R). Washington, D.C. American Psychiatric Association Press: 1987. Washington, D.C.

"Psychopharmacology of Borderline Personality Disorder: A Review," by Rex W. Cowdry, M.D. Journal of Clinical Psychiatry 48:8 (Suppl), August 1987.

Resources for further information:

  • NIMH (National Institute of Mental Health) Extramural Publications Department: 301-443-4513
  • BPD Central: www.bpdcentral.com
  • TARA APD (Treatment and Research Advancements - Association for Personality Disorder): 23 Greene St., New York, NY 10013; 212-966-6895; Web site: www.tara4bpd.org Helpline: 1-888-4-TARA APD (1-888-482-7227); TARAAPD@aol.com.

Reviewed by Rex W. Cowdry, M.D., M.P.H., Senior Scientific Advisor,
American Association of Health Plans, (July 1991)

Permission is granted for this fact sheet to be reproduced in its entirety, but it must include the NAMI name and all contact information.

 

Return to information page on borderline personality disorders .

Return to Home.